Language
Germany

Initial notification · 12.08.2026

Supply shortage: Clarithromycin Eberth 500 mg Pulver zur Herstellung einer Infusionslösung

Affected country: Germany · Reported period: 12.08.2026 – 30.09.2026 · Active ingredient: Clarithromycinlactobionat

CountryGermany
PZN10394201
ENR2185349
Notification typeInitial notification
Start12.08.2026
Expected end30.09.2026
Last update12.08.2026
ReasonOther
ATCJ01FA09
Hospital-relevantYes

Notice context

A supply shortage has been recorded for Clarithromycin Eberth 500 mg Pulver zur Herstellung einer Infusionslösung in Germany. The stated reason is “Other”. The notice concerns the active ingredient Clarithromycinlactobionat and is identified as hospital-relevant.

This information describes the reported supply status and is not medical or pharmaceutical treatment advice. Availability, alternatives and further measures must be assessed for each individual case by the responsible pharmaceutical market participants.

Primary source: PharmNet.Bund / BfArM

Official shortage notice for Germany. Responsibility and update procedures follow the information supplied by the relevant authority.

Check the official notice list →

SEO-relevant topics